Latest news, press releases, and SEC filings for Rapport Therapeutics Inc (RAPP) https://caymanjournal.com/stock/RAPP en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 03:39:16 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is Rapport Therapeutics' **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "report card" and "state of the union" combined into one document, sent directly to its investors. It's designed to give a comprehensive, investor-friendly overview https://caymanjournal.com/stock/RAPP/sec-filing/0001193125-26-171842 https://caymanjournal.com/stock/RAPP/sec-filing/0001193125-26-171842 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 📄 What This Document Is 📰 This filing is a detailed summary of results presented at a major medical conference, the 2026 American Academy of Neurology (AAN) Annual Meeting. It's not a formal SEC filing, but an official presentation of scientific data about the company's lead drug, RAP-219. Bec https://caymanjournal.com/stock/RAPP/sec-filing/0001193125-26-167078 https://caymanjournal.com/stock/RAPP/sec-filing/0001193125-26-167078 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing